Piqray 200 mg

PIQRAY 200 MG tablets contain alpelisib, a medication used in cancer treatment. This oral tablet is manufactured by Novartis Pharmaceuticals Canada Inc. and is designed to target specific cancer cells.

PIQRAY 200 MG tablets are primarily used in the treatment of certain types of cancer. Alpelisib, the active ingredient, is often prescribed in combination with other medications to target specific cancer cells. This medication is used for what is known as targeted therapy, aiming to interfere with the growth and spread of cancer cells.

Common effects of PIQRAY 200 MG tablets may include gastrointestinal issues, fatigue, and skin reactions. Some individuals may experience changes in blood sugar levels or cholesterol. It's important to monitor these effects and consult a healthcare provider if they become severe or persistent.

PIQRAY 200 MG tablets should be handled with care. Store them at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Always follow the instructions provided by your healthcare provider regarding the use of this medication.

PIQRAY 200 MG tablets may interact with certain medications, including those that affect liver enzymes. It's important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Avoid consuming alcohol while taking this medication unless advised otherwise by your healthcare provider.